[{"Assets_0_Q1_USD":163354000.0,"CommonStockSharesOutstanding_0_Q1_shares":34827000.0,"EarningsPerShareBasic_1_Q1_USD":-0.08,"EarningsPerShareDiluted_1_Q1_USD":-0.08,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":-6638000.0,"NetIncomeLoss_1_Q1_USD":-2711000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q1_USD":40133000.0,"StockholdersEquity_0_Q1_USD":143028000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q1_shares":34677000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q1_shares":34677000.0,"Ticker":"GKOS","CIK":"1192448","name":"GLAUKOS CORP","OfficialName":"Glaukos Corporation Common Stock","form":"10-Q","period":"20180331","fy":"2018.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"2869781865.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Electromedical & Electrotherapeutic Apparatus","Market":"NYSE","SP500":"nan","filed":"20180509"}]